Calcineurin in Congenital Nephropathy
Calcineurin in Congenital Nephropathy
批准号:
6766964
负责人:
FENG CHEN
金额:
$15.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2006-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Congenital obstructive nephropathy is the most frequent cause of renal failure in infants and children. The molecular and cellular lesions leading to the congenital obstruction, however, are still largely undetermined.
We hypothesize that calcineurin, a serine/threonine phosphatase, is indispensable for the normal development of the excretory system. We have generated a mouse strain with deletion of the CnB gene in a subset of Pax3 positive cells and their derivatives by Cre-mediated LoxP recombination. These mice have deletion of CnB in the excretory system, including the smooth muscle cells in the ureter. The affected mice have hydronephrosis and hydroureter and die from postnatal renal failure. We plan to further determine the nature, the spectrum, as well as the prenatal and postnatal progression of the congenital nephropathy in the mutants.
Of particular interests, our previous experiments have demonstrated an indispensable role of calcineurin in the formation of the vascular smooth muscle layer around the major blood vessels. Based on this finding and our preliminary results, we further hypothesize that the disruption of calcineurin function in the ureteral smooth muscle or in the innervating nerves causes a defective peristalsis, leading to the obstructive nephropathy. To test this hypothesis, we will determine whether the mutants have anatomical or functional defects preventing effective peristalsis and will identify the causative cellular lesions. Finally, we will study the ontogeny of the urinary tract smooth muscle cells and the potential neuronal contribution to the congenital nephropathy.
The Pax3Cre-CnB mutants we generated have defined genetic modifications and a consistent early onset congenital obstructive nephropathy leading to kidney failure. These mice will serve as a good animal model to study the causes of congenital obstructive nephropathy. Results from the proposed study will also enhance our understanding of the pyeloureteral peristalsis, the ontogeny of ureteral smooth muscle cells, and the role of calcineurin signaling in these processes.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
-
批准号:10544995
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2022
-
负责人:FENG CHEN
-
依托单位:
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
-
批准号:10367242
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2022
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10356306
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
WU-SN-TMC Bio-Analysis Core
-
批准号:10376527
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)
-
批准号:10376523
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10491224
-
项目类别:
-
资助金额:$46.64万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
WU-SN-TMC Bio-Analysis Core
-
批准号:10685428
-
项目类别:
-
资助金额:$82.65万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Washington University Senescence Tissue Mapping Center (WU-SN-TMC)
-
批准号:10685417
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Creating high-resolution multi-omics molecular atlases for developing urogenital organs
-
批准号:10673765
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2021
-
负责人:FENG CHEN
-
依托单位:
Shared Resources Core
-
批准号:10732989
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2017
-
负责人:FENG CHEN
-
依托单位:
Pathogenic Variant Discovery Across a Broad Spectrum of Human Diseases
-
批准号:9376872
-
项目类别:
-
资助金额:$55.48万
-
财政年份:2017
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8041896
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8309407
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8512587
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8146929
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
NFAT SIGNALING IN GLOMERULOSCLEROSIS
-
批准号:8702154
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2010
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:8286427
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:7654047
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:7799784
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTS
-
批准号:8056001
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2009
-
负责人:FENG CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
-
批准号:JCZRQNB202600378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩小建
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
STING-Ca2+-Calcineurin 负反馈环在机体维
持抗病毒天然免疫稳态中的机制研究
-
批准号:Q24H100001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王宁
-
依托单位:
神经介素U通过NMUR1/calcineurin/NAFT 通路介导ARDS神经免疫环路调控的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:戚迪
-
依托单位:
神经分泌NMU通过NMUR1/calcineurin/NFAT通路调控ILC2介导的ARDS免疫炎症的效应及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王导新
-
依托单位:
Rcan2抑制Calcineurin活性决定尾鳍极性再生的机制研究
-
批准号:32170853
-
项目类别:面上项目
-
资助金额:57万元
-
批准年份:2021
-
负责人:陆辉强
-
依托单位:
Calcineurin/CRTC2轴介导的CD206+MerTK+巨噬细胞-肝细胞互作重塑移植肝糖稳态研究
-
批准号:82171757
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:凌琪
-
依托单位:
甲基转移酶 SETD2 调控 Calcineurin 信号抑制线粒体分裂在胶质母细胞瘤细胞增殖与侵袭中的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位: